BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 15808399)

  • 1. Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma.
    Zhang YJ; Chen Y; Ahsan H; Lunn RM; Chen SY; Lee PH; Chen CJ; Santella RM
    Cancer Lett; 2005 Apr; 221(2):135-43. PubMed ID: 15808399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma.
    Zhang YJ; Chen Y; Ahsan H; Lunn RM; Lee PH; Chen CJ; Santella RM
    Int J Cancer; 2003 Feb; 103(4):440-4. PubMed ID: 12478658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
    Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ
    Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RASSF1A hypermethylation is associated with aflatoxin B1 and polycyclic aromatic hydrocarbon exposure in hepatocellular carcinoma.
    Feng Y; Xue WJ; Li P; Sha ZY; Huang H; Rui L; Li HX; Mao QS
    Hepatogastroenterology; 2012 Sep; 59(118):1883-8. PubMed ID: 22172412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas.
    Tchou JC; Lin X; Freije D; Isaacs WB; Brooks JD; Rashid A; De Marzo AM; Kanai Y; Hirohashi S; Nelson WG
    Int J Oncol; 2000 Apr; 16(4):663-76. PubMed ID: 10717233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
    Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.
    Esteller M; Corn PG; Urena JM; Gabrielson E; Baylin SB; Herman JG
    Cancer Res; 1998 Oct; 58(20):4515-8. PubMed ID: 9788592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
    Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
    Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients.
    Wang J; Qin Y; Li B; Sun Z; Yang B
    Clin Biochem; 2006 Apr; 39(4):344-8. PubMed ID: 16527261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between GSTP1 gene aberrant promoter methylation and prognosis in surgically resected hepatocellular carcinoma patients from the Basque Country (Northern Spain).
    Anzola M; Cuevas N; López-Martínez M; Saiz A; Burgos JJ; de Pancorbo MM
    Liver Int; 2003 Aug; 23(4):249-54. PubMed ID: 12895264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls.
    Chen SY; Wang LY; Lunn RM; Tsai WY; Lee PH; Lee CS; Ahsan H; Zhang YJ; Chen CJ; Santella RM
    Int J Cancer; 2002 May; 99(1):14-21. PubMed ID: 11948486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma.
    Su PF; Lee TC; Lin PJ; Lee PH; Jeng YM; Chen CH; Liang JD; Chiou LL; Huang GT; Lee HS
    Int J Cancer; 2007 Sep; 121(6):1257-64. PubMed ID: 17534893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of the GSTP1 and GSTM1 genes and PAH-DNA adducts in human mononuclear white blood cells.
    Butkiewicz D; Grzybowska E; Phillips DH; Hemminki K; Chorazy M
    Environ Mol Mutagen; 2000; 35(2):99-105. PubMed ID: 10712743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance and association of GSTP1 hypermethylation with hepatocellular carcinoma: A meta-analysis.
    Li Y; Cai Y; Chen H; Mao L
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S486-S489. PubMed ID: 29970711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.
    Lee S; Lee HJ; Kim JH; Lee HS; Jang JJ; Kang GH
    Am J Pathol; 2003 Oct; 163(4):1371-8. PubMed ID: 14507645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells.
    Singal R; van Wert J; Bashambu M
    Cancer Res; 2001 Jun; 61(12):4820-6. PubMed ID: 11406558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of APC, GSTP1 and SOCS1 promoter methylation with the risk of hepatocellular carcinoma: a meta-analysis.
    Liu M; Cui LH; Li CC; Zhang L
    Eur J Cancer Prev; 2015 Nov; 24(6):470-83. PubMed ID: 25853848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.